Literature DB >> 25128389

Mesenchymal change and drug resistance in neuroblastoma.

Jessica A Naiditch1, Chunfa Jie2, Timothy B Lautz1, Songtao Yu3, Sandra Clark3, Dimitry Voronov3, Fei Chu4, Mary Beth Madonna1.   

Abstract

BACKGROUND: Metastatic initiation has many phenotypic similarities to epithelial-to-mesenchymal transition, including loss of cell-cell adhesion, increased invasiveness, and increased cell mobility. We have previously demonstrated that drug resistance is associated with a metastatic phenotype in neuroblastoma (NB). The purpose of this project was to determine if the development of doxorubicin resistance is associated with characteristics of mesenchymal change in human NB cells.
MATERIALS AND METHODS: Total RNA was isolated from wild type (WT) and doxorubicin-resistant (DoxR) human NB cell lines (SK-N-SH and SK-N-BE(2)C) and analyzed using the Illumina Human HT-12 version 4 Expression BeadChip. Differentially expressed genes (DEGs) were identified. Volcano plots and heat maps were generated. Genes of interest with a fold change in expression >1.5 and an adjusted P < 0.1 were analyzed. Immunofluorescence (IF) and Western blot analysis confirmed microarray results of interest. Matrigel invasion assay and migration wounding assays were performed.
RESULTS: Volcano plots and heat maps visually demonstrated a similar pattern of DEGs in the SK-N-SH and SK-N-BE(2)C DoxR cell lines relative to their parental WT lines. Venn diagramming revealed 1594 DEGs common to both DoxR cell lines relative to their parental cell lines. Network analysis pointed to several significantly upregulated epithelial-to-mesenchymal transition pathways, through TGF-beta pathways via RhoA, PI3K, and ILK and via SMADs, as well as via notch signaling pathways. DoxR cell lines displayed a more invasive phenotype than respective WT cell lines.
CONCLUSIONS: Human SK-N-SH and SK-N-BE(2)C NB cells display characteristics of mesenchymal change via multiple pathways in the transition to a drug-resistant state.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Drug resistance; Long-term drug exposure; Mesenchymal change; Neuroblastoma

Mesh:

Substances:

Year:  2014        PMID: 25128389     DOI: 10.1016/j.jss.2014.07.018

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  4 in total

1.  Epithelial-mesenchymal, mesenchymal-epithelial, and endothelial-mesenchymal transitions in malignant tumors: An update.

Authors:  Simona Gurzu; Sabin Turdean; Attila Kovecsi; Anca Otilia Contac; Ioan Jung
Journal:  World J Clin Cases       Date:  2015-05-16       Impact factor: 1.337

2.  Development of a prognostic model for children with neuroblastoma based on necroptosis-related genes.

Authors: 
Journal:  Front Genet       Date:  2022-08-05       Impact factor: 4.772

3.  Antiproliferative and apoptotic effect of LY2090314, a GSK-3 inhibitor, in neuroblastoma in vitro.

Authors:  Selvi Kunnimalaiyaan; Victoriana K Schwartz; Iris Alao Jackson; T Clark Gamblin; Muthusamy Kunnimalaiyaan
Journal:  BMC Cancer       Date:  2018-05-11       Impact factor: 4.430

4.  Cancer stem cells in neuroblastoma therapy resistance.

Authors:  Natarajan Aravindan; Drishti Jain; Dinesh Babu Somasundaram; Terence S Herman; Sheeja Aravindan
Journal:  Cancer Drug Resist       Date:  2019-11-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.